Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in macroalbuminuric, diabetic patients.

被引：0
|
作者：
Sidharta, PN
Wagner, FD
Jungik, A
Halabi, A
Dingemanse, J
机构：
[1] Actel Pharmaceut Ltd, Allschwil, Switzerland
[2] 3ClinRes AG, Hennigsdorf, Germany
[3] PHAROS GmbH, Ulm, Germany
[4] IKP GmbH, Kiel, Germany
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 45卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
47
引用
收藏
页码：1078 / 1078
页数：1
相关论文
共 50 条
  • [31] Molecular modeling of the urotensin-II receptor complex
    Grieco, Paolo
    Lavecchia, Antonio
    Campiglia, Pietro
    Lama, Teresa
    Rovero, Paolo
    Carotenuto, Alfonso
    Patacchini, Riccardo
    Maggi, Carlo A.
    Novellino, Ettore
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 748 - 749
  • [32] Development of new urotensin-II receptor ligands
    Campiglia, Pietro
    Carotenuto, Alfonso
    Patacchini, Riccardo
    Maggi, Carlo A.
    Novellino, Ettore
    Rovero, Paolo
    Grieco, Paolo
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 746 - 747
  • [33] Three-dimensional model of the human urotensin-II receptor: Docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model
    Lescot, Elodie
    Santos, Jana Sopkova-de Oliveira
    Colloc'h, Nathalie
    Rodrigo, Jordi
    Milazzo-Segalas, Isabelle
    Bureau, Ronan
    Rault, Sylvain
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (01) : 173 - 184
  • [34] The effects of urotensin-II on proliferation of pheochromocytoma cells and mRNA expression of urotensin-II and its receptor in pheochromocytoma tissues
    Zeng, Zheng-Pei
    Liu, Guo-Qiang
    Li, Han-Zhong
    Fan, Xin-Rong
    Liu, Dong-Mei
    Tong, An-Li
    Zheng, Xin
    Liu, Chang
    PHEOCHROMOCYTOMA, 2006, 1073 : 284 - 289
  • [35] The neuromedin B receptor antagonist, BIM-23127, is a potent antagonist at human and rat urotensin-II receptors
    Herold, CL
    Behm, DJ
    Buckley, PT
    Foley, JJ
    Wixted, WE
    Sarau, HM
    Douglas, SA
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (02) : 203 - 207
  • [36] Non-peptidic urotensin-II receptor modulators
    Jin, J
    Douglas, SA
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (04) : 467 - 479
  • [37] Isochromanone-based urotensin-II receptor agonists
    Lehmann, F
    Currier, EA
    Olsson, R
    Hacksell, U
    Luthman, K
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (08) : 3057 - 3068
  • [38] Ligand-Supported Purification of the Urotensin-II Receptor
    Du, Ann T.
    Onan, Doene
    Dinh, Diem T.
    Lew, Michael J.
    Ziogas, James
    Aguilar, Marie-Isabel
    Pattenden, Leonard K.
    Thomas, Walter G.
    MOLECULAR PHARMACOLOGY, 2010, 78 (04) : 639 - 647
  • [39] Use of Diverse Chemometric and Validation Methods to Accurately Predict Human Urotensin-II Receptor Antagonist Activity
    Pandey, Anubhuti
    Paliwal, Sarvesh
    Yadav, Rakesh
    Paliwal, Shailendra
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2015, 11 (04) : 361 - 373
  • [40] GSK248451, a novel peptidic urotensin-II receptor antagonist, potently inhibits urotensin-II-induced vasoconstriction both in vitro and in vivo
    Behm, DJ
    Stankus, GP
    Doe, CP
    Willette, RN
    Sarau, HM
    Foley, JJ
    Buckley, PT
    Schmidt, DB
    Wixted, WE
    Nuthulaganti, P
    Fornwald, JA
    Ames, RS
    Camarda, V
    Aiyar, NV
    Douglas, SA
    CIRCULATION, 2005, 112 (17) : U203 - U203
12345